Medicover Genetics endometrial microbiome analysis: A comprehensive assessment for personalised treatment and improved fertility care

Medicover Genetics is pleased to highlight ebiom+, an advanced solution for endometrial microbiome analysis introduced earlier this year.

The endometrial microbiome is increasingly recognised as a factor in reproductive health, and imbalances in microbial composition, particularly reduced Lactobacillus dominance, have been linked to unexplained infertility, recurrent implantation failure, and pregnancy loss. Persistent inflammation of the endometrial lining, called chronic endometritis (CE), is frequently asymptomatic but may also undermine reproductive success.

• offers a comprehensive approach to evaluating these factors by combining
• to assess the microbial profile of the endometrium () and identify normal conditions, dysbiosis (abnormal colonisation), and potential pathogens. These results lead to personalised treatments and improved fertility care.
• to detect pathogens associated with CE (). This enables an accurate diagnosis of the infection and targeted treatment.

We provide clinically validated insights and actionable reports to guide the targeted use of probiotics or antibiotics for better patient care. Endometrial microbiome analysis is emerging as a critical factor in reproductive outcomes, and ebiom+ supports clinicians with a more informed assessment of endometrial health in fertility care.

For more details, visit our page.